Mark A. Schenerman

2.1k total citations
29 papers, 1.6k citations indexed

About

Mark A. Schenerman is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Mark A. Schenerman has authored 29 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Infectious Diseases. Recurrent topics in Mark A. Schenerman's work include Protein purification and stability (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Viral gastroenteritis research and epidemiology (5 papers). Mark A. Schenerman is often cited by papers focused on Protein purification and stability (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Viral gastroenteritis research and epidemiology (5 papers). Mark A. Schenerman collaborates with scholars based in United States, Netherlands and Sweden. Mark A. Schenerman's co-authors include Robert Strouse, José R. Casas‐Finet, Chris D. Geddes, Anatoly I. Dragan, James B. McGivney, Ziping Wei, Guillermo I. Tous, Radmila Pavlović, Michael S. Kilberg and Anthony R. Mire‐Sluis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Analytical Chemistry and Nature Reviews Drug Discovery.

In The Last Decade

Mark A. Schenerman

29 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Schenerman United States 17 977 394 267 212 180 29 1.6k
Robert Strouse United States 16 1.0k 1.1× 377 1.0× 258 1.0× 244 1.2× 202 1.1× 22 1.8k
Koji Matsuoka Japan 30 1.8k 1.8× 379 1.0× 138 0.5× 259 1.2× 153 0.8× 179 3.3k
Jennifer A. Maynard United States 29 1.3k 1.3× 722 1.8× 344 1.3× 261 1.2× 621 3.5× 76 2.6k
Pavel I. Kitov Canada 27 1.9k 1.9× 556 1.4× 140 0.5× 126 0.6× 313 1.7× 69 2.9k
Ralph L. McDade United States 8 805 0.8× 278 0.7× 404 1.5× 162 0.8× 177 1.0× 10 1.5k
Christopher B. Howard Australia 24 951 1.0× 276 0.7× 540 2.0× 61 0.3× 242 1.3× 89 1.8k
Rolf Misselwitz Germany 26 1.2k 1.3× 219 0.6× 122 0.5× 69 0.3× 519 2.9× 77 2.2k
Reiko T. Lee United States 26 2.1k 2.1× 333 0.8× 143 0.5× 130 0.6× 551 3.1× 60 2.9k
Jonas Ångström Sweden 31 1.3k 1.4× 173 0.4× 65 0.2× 150 0.7× 459 2.5× 97 2.7k
Roger New United Kingdom 18 1.0k 1.1× 123 0.3× 164 0.6× 172 0.8× 189 1.1× 53 2.2k

Countries citing papers authored by Mark A. Schenerman

Since Specialization
Citations

This map shows the geographic impact of Mark A. Schenerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Schenerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Schenerman more than expected).

Fields of papers citing papers by Mark A. Schenerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Schenerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Schenerman. The network helps show where Mark A. Schenerman may publish in the future.

Co-authorship network of co-authors of Mark A. Schenerman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Schenerman. A scholar is included among the top collaborators of Mark A. Schenerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Schenerman. Mark A. Schenerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kijanka, Grzegorz, Jared S. Bee, Mark A. Schenerman, et al.. (2019). Monoclonal Antibody Dimers Induced by Low pH, Heat, or Light Exposure Are Not Immunogenic Upon Subcutaneous Administration in a Mouse Model. Journal of Pharmaceutical Sciences. 109(1). 730–738. 12 indexed citations
2.
Kijanka, Grzegorz, Jared S. Bee, Yuling Wu, et al.. (2018). Submicron Size Particles of a Murine Monoclonal Antibody Are More Immunogenic Than Soluble Oligomers or Micron Size Particles Upon Subcutaneous Administration in Mice. Journal of Pharmaceutical Sciences. 107(11). 2847–2859. 56 indexed citations
3.
Yang, Harry, Ziping Wei, & Mark A. Schenerman. (2014). A Statistical Approach to Determining Criticality of Residual Host Cell DNA. Journal of Biopharmaceutical Statistics. 25(2). 234–246. 1 indexed citations
4.
Dragan, Anatoly I., José R. Casas‐Finet, Robert Strouse, et al.. (2012). Distance Dependence of Metal-Enhanced Fluorescence. Plasmonics. 7(4). 739–744. 74 indexed citations
5.
Zhang, L., et al.. (2012). Implementation of Parallelism Testing for Four-Parameter Logistic Model in Bioassays. PDA Journal of Pharmaceutical Science and Technology. 66(3). 262–269. 9 indexed citations
6.
Dragan, Anatoly I., Radmila Pavlović, James B. McGivney, et al.. (2012). SYBR Green I: Fluorescence Properties and Interaction with DNA. Journal of Fluorescence. 22(4). 1189–1199. 234 indexed citations
7.
Jiang, Xu‐Rong, An Song, Svetlana Bergelson, et al.. (2011). Advances in the assessment and control of the effector functions of therapeutic antibodies. Nature Reviews Drug Discovery. 10(2). 101–111. 241 indexed citations
9.
McGivney, James B., Eric Bishop, Kenneth W. Miller, et al.. (2010). Evaluation of a synthetic peptide as a replacement for the recombinant fusion protein of respiratory syncytial virus in a potency ELISA. Journal of Pharmaceutical and Biomedical Analysis. 54(3). 572–576. 4 indexed citations
10.
Dragan, Anatoly I., et al.. (2010). Metal-enhanced PicoGreen® fluorescence: Application to fast and ultra-sensitive pg/ml DNA quantitation. Journal of Immunological Methods. 362(1-2). 95–100. 21 indexed citations
11.
Dragan, Anatoly I., et al.. (2010). Characterization of PicoGreen Interaction with dsDNA and the Origin of Its Fluorescence Enhancement upon Binding. Biophysical Journal. 99(9). 3010–3019. 149 indexed citations
12.
Dragan, Anatoly I., et al.. (2009). Metal-enhanced PicoGreen fluorescence: Application for double-stranded DNA quantification. Analytical Biochemistry. 396(1). 8–12. 34 indexed citations
13.
Wei, Ziping, Vladimir I. Razinkov, Alla Polozova, et al.. (2007). Biophysical characterization of influenza virus subpopulations using field flow fractionation and multiangle light scattering: Correlation of particle counts, size distribution and infectivity. Journal of Virological Methods. 144(1-2). 122–132. 90 indexed citations
14.
Wei, Ziping, Jinhua Feng, Hung‐Yu Lin, et al.. (2007). Identification of a Single Tryptophan Residue as Critical for Binding Activity in a Humanized Monoclonal Antibody against Respiratory Syncytial Virus. Analytical Chemistry. 79(7). 2797–2805. 119 indexed citations
15.
Peden, Keith, et al.. (2006). Lot Release and Characterization Testing of Live-Virus-Based Vaccines and Gene Therapy Products, Part 2 Case Studies and Discussion. 4 indexed citations
16.
Schenerman, Mark A., et al.. (2002). A novel and convenient transformation of nitriles to aldehydes. Tetrahedron Letters. 43(8). 1395–1396. 21 indexed citations
17.
Langermann, Solomon, Roland Möllby, Jeanne E. Burlein, et al.. (2000). Vaccination with FimH Adhesin Protects Cynomolgus Monkeys from Colonization and Infection by UropathogenicEscherichia coli. The Journal of Infectious Diseases. 181(2). 774–778. 255 indexed citations
18.
Schenerman, Mark A., et al.. (1994). Determination of a Monoclonal Antibody Binding Activity Using ImmunoDetection. Analytical Biochemistry. 217(2). 241–247. 4 indexed citations
19.
Schenerman, Mark A., et al.. (1988). Induction of system A amino acid transport through long‐term treatment with ouabain: Correlation with increased (Na+/K+)‐ATpase activity. Journal of Cellular Physiology. 135(2). 157–162. 7 indexed citations
20.
Leister, Kirk J., Mark A. Schenerman, & Efraim Racker. (1988). Energetic mechanism of system a amino acid transport in normal and transformed mouse fibroblasts. Journal of Cellular Physiology. 135(2). 163–168. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026